Mukka Proteins Limited (MUKKA) — Board Meeting | 12 August 2026(4 announcements)

Mukka Proteins announced the outcome of its August 12, 2026 board meeting, approving unaudited Q1 FY2026 results with total income of ₹4,912.47 crores and profit after tax of ₹186.34 million, cancelling a proposed ₹75 crores NCD issuance, investing [amount not verified] for a 25.98% stake in Swachha Eco Solutions, and reappointing four directors including MD & CEO Kalandan Mohammed Haris and CFO Kalandan Mohammed Althaf. The filing also details reappointments of three independent directors and three key managerial personnel effective January 2027, alongside an auditor's review of Q1 results showing revenue of ₹4,058.56 million and profit after tax of ₹194.07 million for the quarter ended June 30, 2026.

Mukka Proteins Limited announced on 12 August 2026 that its board withdrew the previously approved proposal to issue up to ₹75 crores of senior secured NCDs via private placement, a plan that had been considered on 15 May 2026 but was never executed or allotted.

Mukka Proteins Limited announced on 12 August 2026 that its board approved a strategic investment in Swachha Eco Solutions Private Limited, acquiring up to 26,500 shares representing 25.98% equity for a total consideration of [amount not verified] in cash, targeting completion by 31 December 2026.

Mukka Proteins announced board changes effective 15th January 2027, reappointing four directors including Kalandan Mohammed Haris as Managing Director and CEO for a five-year term until 19th January 2032, and Kalandan Mohammed Althaf as Whole-Time Director and CFO for the same period, subject to shareholder approval at the 16th AGM.